Siegfried, a global CDMO for the pharmaceutical industry, has signed binding agreements with an affiliate of SK Capital ...

Around 100 participants with type 2 diabetes mellitus will be enrolled across US sites.

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent ...

Amgen Inc. (NASDAQ:AMGN) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, Bernstein ...

The Morgan Lewis cross-functional and cross-jurisdiction life sciences and healthcare teams were represented in San Francisco ...

Contract development and manufacturing organization (CDMO) Alcami announced its purchase of a third facility in North ...

Swiss CDMO Sigfried has been on a growth jag over the last decade. | Siegfried has signed agreements to acquire the controlled drug substance businesses of the Noramco Group and Extractas Bioscience.

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, conducted a Type C meeting with the U.S. Food ...

New streamlined, mobile-optimized shopping experience, allows consumers to purchase BUZZ BOMB™ directly, access exclusive promotions and engage with the brand through educational and lifestyle content ...

AB Science has secured a patent in Japan, valid through February 2041, covering the use of masitinib for progressive forms of MS.

Every year, university researchers discover potential new drugs, diagnostics, and medical devices that could transform patient care. Yet many of those ideas stall in the "valley of death," the stretch ...

The pharmaceutical company is running investigational new drug experiments, studies required by the FDA to demonstrate the ...